• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚六亚甲基双胍治疗合并真菌感染的棘阿米巴角膜炎

Treatment of Acanthamoeba keratitis combined with fungal infection with polyhexamethylene biguanide.

作者信息

Tien S H, Sheu M M

机构信息

Department of Ophthalmology, Kaohsiung Medical University, Taiwan, Republic of China.

出版信息

Kaohsiung J Med Sci. 1999 Nov;15(11):665-73.

PMID:10630064
Abstract

From July 1996 to March 1997, three cases of Acanthamoeba keratitis combined with fungal infection were diagnosed and treated at our ophthalmic department. Specimens from all of these cases were obtained by corneal scraping, keratectomy and anterior chamber paracentesis. The diagnosis was confirmed by either the results of smear test or pathology reports. All of these patients received aggressive treatment with polyhexamethylene biguanide (PHMB) 0.02%, fluconazole, and anegyn eye drops. After the infection had been controlled without extension, therapeutic penetrating keratoplasty was performed on all of these patients despite the existence of infiltration beyond the edge of the graft. Postoperatively, eye drops were tapered gradually, and treatment was continued for 1 to 2 months. All three cases achieved good results and there was no recurrence of infection. Two cases had visual acuity of 20/100 and 20/20, while the other one perceived hand movement only due to later graft rejection. These cases suggest that early diagnosis and immediate use of PHMB and anti-fungal agents are effective in the treatment of Acanthamoeba keratitis combined with fungal infection.

摘要

1996年7月至1997年3月,我院眼科诊断并治疗了3例棘阿米巴角膜炎合并真菌感染的病例。所有这些病例的标本均通过角膜刮片、角膜切除术和前房穿刺术获取。通过涂片检查结果或病理报告确诊。所有这些患者均接受了0.02%聚六亚甲基双胍(PHMB)、氟康唑和阿内吉滴眼液的积极治疗。在感染得到控制且无扩散后,尽管移植边缘存在浸润,所有这些患者均接受了治疗性穿透性角膜移植术。术后,滴眼液逐渐减量,并持续治疗1至2个月。所有3例均取得良好效果,且无感染复发。2例视力为20/100和20/20,而另一例因后期移植排斥反应仅能感知手动。这些病例表明,早期诊断并立即使用PHMB和抗真菌药物对治疗棘阿米巴角膜炎合并真菌感染有效。

相似文献

1
Treatment of Acanthamoeba keratitis combined with fungal infection with polyhexamethylene biguanide.聚六亚甲基双胍治疗合并真菌感染的棘阿米巴角膜炎
Kaohsiung J Med Sci. 1999 Nov;15(11):665-73.
2
Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis.聚六亚甲基双胍和氯己定作为单药治疗棘阿米巴角膜炎的比较。
Am J Ophthalmol. 2008 Jan;145(1):130-5. doi: 10.1016/j.ajo.2007.08.040. Epub 2007 Nov 8.
3
[Acanthamoeba keratitis: about the first two Tunisian cases].[棘阿米巴角膜炎:关于突尼斯的前两例病例]
Bull Soc Pathol Exot. 2007 Feb;100(1):41-2.
4
Successful medical treatment of Acanthamoeba keratitis.棘阿米巴角膜炎的成功医学治疗。
Int Ophthalmol. 1997;21(4):223-7. doi: 10.1023/a:1006055918101.
5
Benefit of polyhexamethylene biguanide in Fusarium keratitis.聚六亚甲基双胍在镰刀菌角膜炎中的益处。
Ophthalmic Res. 2012;48(4):171-6. doi: 10.1159/000337140. Epub 2012 Jun 16.
6
Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis.米替福新和聚六亚甲基双胍:一种治疗棘阿米巴角膜炎的新药组合。
Clin Exp Ophthalmol. 2014 Mar;42(2):151-8. doi: 10.1111/ceo.12120. Epub 2013 May 21.
7
Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide.聚六亚甲基双胍治疗棘阿米巴角膜炎
Ophthalmology. 1992 Feb;99(2):185-91. doi: 10.1016/s0161-6420(92)31994-3.
8
Bilateral Acanthamoeba keratitis with late recurrence of the infection in a corneal graft: a case report.双侧棘阿米巴角膜炎伴角膜移植术后感染晚期复发:1例报告
Eur J Ophthalmol. 2003 Apr;13(3):311-4. doi: 10.1177/112067210301300312.
9
Is polyhexamethylene biguanide alone effective for Acanthamoeba keratitis?聚六亚甲基双胍单独用于棘阿米巴角膜炎有效吗?
Cornea. 1998 May;17(3):345-6. doi: 10.1097/00003226-199805000-00019.
10
[Acanthamoeba keratitis treated with propamidine and polyhexamethyl biguanide (PHMB)].用丙脒腙和聚六亚甲基双胍(PHMB)治疗的棘阿米巴角膜炎
Rev Med Chil. 2002 Apr;130(4):396-401.

引用本文的文献

1
Recent in vitro advances in the ocular antimicrobial agents against Acanthamoeba.近期眼部抗棘阿米巴抗菌剂的体外研究进展。
Int J Parasitol Drugs Drug Resist. 2025 Apr;27:100586. doi: 10.1016/j.ijpddr.2025.100586. Epub 2025 Feb 21.
2
Case Report: Corneal Coinfection with Fungus and : Report of Two Patients and Literature Review.病例报告:真菌和 的角膜合并感染:两例患者报告及文献复习。
Am J Trop Med Hyg. 2018 Sep;99(3):805-808. doi: 10.4269/ajtmh.18-0158. Epub 2018 Jul 12.
3
The Development of Drugs against Acanthamoeba Infections.
抗棘阿米巴感染药物的研发
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6441-6450. doi: 10.1128/AAC.00686-16. Print 2016 Nov.